PT-141 (Bremelanotide)

Known safety concerns, contraindications, and risk factors.

Immediate Effects (5)

Long-Term Risks (3)

Sourcing Dangers (3)

Contraindications (4)

Uncontrolled hypertension or known cardiovascular disease

Strictly contraindicated due to transient blood pressure elevation with every dose.

Monitor

Concurrent naltrexone therapy (opioid or alcohol addiction treatment)

PT-141 reduces naltrexone bioavailability by 40-60%, risking treatment failure and relapse.

Monitor

Pregnancy or breastfeeding

Animal data demonstrate fetal harm. Unknown if PT-141 passes into human milk.

Monitor

Reliance on oral medications requiring rapid absorption

Slowed gastric emptying may delay or reduce absorption of oral antibiotics, analgesics, and other time-sensitive medications.

Monitor

Auto-Generated Safety Flags

PT-141 is strictly contraindicated in patients with uncontrolled hypertension or known cardiovascular disease due to acute blood pressure increases of 6 mmHg systolic and 3 mmHg diastolic per dose.

PT-141 significantly decreases oral naltrexone bioavailability by 40-60%. Co-administration may cause addiction treatment failure and relapse risk.

Nausea affects approximately 40% of users and is the primary cause of treatment discontinuation. Start at the lowest effective dose to assess tolerance.

Irreversible focal hyperpigmentation may occur, particularly with daily use or exceeding 8 doses per month. Skin darkening of the face, gums, and breasts may be permanent.

PT-141 is NOT FDA-approved for use in men or postmenopausal women. All use in these populations is off-label with a less well-characterised safety profile.

PT-141 slows gastric emptying and may reduce absorption of oral medications including antibiotics and pain relievers.

PT-141 is not interchangeable with Melanotan II. MT-II has higher MC1R activity linked to melanoma risk in human case reports.

PT-141 is contraindicated during pregnancy. Animal studies documented post-implantation loss and developmental delays at supratherapeutic doses.

Continue